Speaker illustration

Professor Yuri Pozdnyakov

Moscow Regional Cardiology Center, Zhukovsky (Russian Federation)

Clinical acceptability of trimetazidine 80 mg once daily versus trimetazidine modified release 35 mg twice daily in chronic stable angina pectoris

Event: ESC Congress 2016

Topic: Angina pectoris stable

Session: Stable angina - Treatment and outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb